Testing effectiveness (Phase 2)Ended earlyNCT01582048
What this trial is testing
Multicenter Study of Peritransplantation Immunosuppression for Mismatched Hematopoietic Cell Transplantation After Reduced Intensity Conditioning
Who this might be right for
Patients Receiving Mismatched Allogeneic HCT
Prof. Dr. med. Wolfgang Bethge 9